Horm Metab Res 2008; 40(10): 668-673
DOI: 10.1055/s-2008-1078716
Original Basic

© Georg Thieme Verlag KG Stuttgart · New York

WNT-4 mRNA Expression in Human Adrenocortical Tumors and Cultured Adrenal Cells

T. Kuulasmaa 1 , J. Jääskeläinen 1 , S. Suppola 1 , T. Pietiläinen 2 , P. Heikkilä 3 , S. Aaltomaa 4 , V.-M. Kosma 2 , 5 , R. Voutilainen 1
  • 1Department of Pediatrics, Kuopio University and University Hospital, Kuopio, Finland
  • 2Department of Pathology, Kuopio University Hospital, Kuopio, Finland
  • 3Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  • 4Department of Urology, Kuopio University Hospital, Kuopio, Finland
  • 5Department of Pathology and Forensic Medicine, University of Kuopio, Kuopio, Finland
Further Information

Publication History

received 06.08.2007

accepted 14.02.2008

Publication Date:
13 June 2008 (online)

Abstract

The members of the Wnt glycoprotein family are important in embryogenesis and adult tissue homeostasis, and deletion of Wnt-4 gene in mice leads to improper development of many organs including the adrenals. The objective of this study was to investigate the expression of WNT-4 gene in human adrenals and adrenocortical tumors. The WNT-4 mRNA expression (analyzed by quantitative real-time RT-PCR) was significantly higher in Conn's adenomas (p<0.01) and lower in Cushing's adenomas, virilizing carcinomas and fetal adrenals (p<0.05) compared with normal adult adrenals. WNT-4 mRNA expression was clearly upregulated by ACTH and 8-bromo-cAMP (8-BrcAMP) in primary cultures of normal adult adrenocortical cells, but downregulated by 8-BrcAMP and 12-O-tetradecanoylphorbol-13-acetate (TPA) in human NCI-H295R adrenocortical carcinoma cells. Angiotensin II tended to increase WNT-4 mRNA expression at 24 hours and decreased it at 48 hours time point in both cell culture types. The abundant WNT-4 mRNA expression in Conn's adenomas and its hormonal regulation in adrenocortical cells suggest a role for WNT-4 in human adrenocortical function.

References

  • 1 Logan CY, Nusse R. The Wnt signaling pathway in development and disease.  Annu Rev Cell Dev Biol. 2004;  20 781-810
  • 2 Dale TC. Signal transduction by the Wnt family of ligands.  Biochem J. 1998;  329 209-223
  • 3 Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway.  J Cell Sci. 2003;  116 2627-2634
  • 4 Huelsken J, Behrens J. The Wnt signalling pathway.  J Cell Sci. 2002;  115 3977-3978
  • 5 Miller JR. The Wnts.  Genome Biol. 2002;  3 , reviews 3001.1–3001.15
  • 6 Moon RT, Kohn AD, Ferrari GV De, Kaykas A. WNT and beta-catenin signalling: diseases and therapies.  Nat Rev Genet. 2004;  5 691-701
  • 7 Vainio S, Heikkilä M, Kispert A, Chin N, MacMahon AP. Female development in mammals is regulated by Wnt-4 signalling.  Nature. 1999;  397 405-409
  • 8 Bernard P, Harley VR. Wnt4 action in gonadal development and sex determination.  Int J Biochem Cell Biol. 2007;  39 31-43
  • 9 Mizusaki H, Kawabe K, Mukai T, Ariyoshi E, Kasahara M, Yoshioka H, Swain A, Morohashi K. Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad.  Mol Endocrinol. 2003;  17 507-519
  • 10 Heikkilä M, Prunskaite R, Naillat F, Itäranta P, Vuoristo J, Leppäluoto J, Peltoketo H, Vainio S. The partial female to male sex reversal in Wnt-4-deficient females involves induced expression of testosterone biosynthetic genes and testosterone production, and depends on androgen action.  Endocrinology. 2005;  146 4016-4023
  • 11 Jordan BK, Shen JH, Olaso R, Ingraham HA, Vilain E. Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy.  Proc Natl Acad Sci USA. 2003;  100 10866-10871
  • 12 Jeays-Ward K, Dandonneau M, Swain A. Wnt4 is required for proper male as well as female sexual development.  Dev Biol. 2004;  276 431-440
  • 13 Jordan BK, Mohammed M, Ching ST, Delot E, Chen XN, Dewing P, Swain A, Rao PN, Elejalde BR, Vilain E. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.  Am J Hum Genet. 2001;  68 1102-1109
  • 14 Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ. A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman.  N Engl J Med. 2004;  351 792-798
  • 15 Suwa T, Chen M, Hawks CL, Hornsby PJ. Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex.  J Endocrinol. 2003;  178 149-158
  • 16 Peltoketo H, Allinen M, Vuosku J, Kujala S, Lundan T, Salminen A, Winqvist R, Vainio S. Characterization and expression of the human WNT4; lack of associated germline mutations in high-to moderate-risk breast and ovarian cancer.  Cancer Lett. 2004;  213 83-90
  • 17 Heikkilä M, Peltoketo H, Leppäluoto J, Ilves M, Vuolteenaho O, Vainio S. Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production.  Endocrinology. 2002;  143 4358-4365
  • 18 Arola J, Liu J, Heikkilä P, Ilvesmäki V, Salmenkivi K, Voutilainen R, Kahri AI. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.  J Endocrinol. 2000;  165 223-229
  • 19 Voutilainen R, Erämaa M, Ritvos O. Hormonally regulated inhibin gene expression in human fetal and adult adrenals.  J Clin Endocrinol Metab. 1991;  73 1026-1030
  • 20 Vänttinen T, Kuulasmaa T, Liu J, Voutilainen R. Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells.  J Clin Endocrinol Metab. 2002;  87 4257-4263
  • 21 Utriainen P, Liu J, Kuulasmaa T, Voutilainen R. Inhibition of DNA methylation increases follistatin expression and secretion in the human adrenocortical cell line NCI-H295R.  J Endocrinol. 2006;  188 305-310
  • 22 Eberhart CG, Argani P. Wnt signaling in human development: beta-catenin nuclear translocation in fetal lung, kidney, placenta, capillaries, adrenal, and cartilage.  Pediatr Dev Pathol. 2001;  4 351-357
  • 23 Lyons JP, Mueller UW, Ji H, Everett C, Fang X, Hsieh JC, Barth AM, McCrea PD. Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells.  Exp Cell Res. 2004;  298 369-387
  • 24 Hou X, Tan Y, Li M, Dey SK, Das SK. Canonical Wnt signaling is critical to estrogen-mediated uterine growth.  Mol Endocrinol. 2004;  18 3035-3049
  • 25 Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagnere AM, Rene-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.  Cancer Res. 2005;  65 7622-7627
  • 26 Chen M, Hornsby PJ. Adenovirus-delivered DKK3/WNT4 and steroidogenesis in primary cultures of adrenocortical cells.  Horm Metab Res. 2006;  38 549-555

Correspondence

R. Voutilainen

Department of Pediatrics

Kuopio University Hospital

P.O. Box 1777

70211 Kuopio

Finland

Phone: +358/17/17 23 91

Fax: +358/17/17 24 10

Email: Raimo.Voutilainen@uku.fi

    >